Unauthenticated Network Vulnerability in Oracle Life Sciences Central Designer by Oracle
CVE-2026-21923

6.5MEDIUM

Key Information:

Vendor

Oracle
Status
Oracle Life Sciences Central Designer
Vendor
CVE Published:
20 January 2026

What is CVE-2026-21923?

The vulnerability in Oracle Life Sciences Central Designer allows unauthenticated attackers with HTTP access to exploit the system. This could lead to unauthorized data modifications, including updates, insertions, deletions, and the potential for unauthorized read access to a portion of the accessible data. This exposes sensitive information and undermines the integrity of the system, posing significant risks for organizations utilizing this product.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Oracle Life Sciences Central Designer 7.0.1.0

References

https://www.oracle.com/security-alerts/cpujan2026.html
vendor-advisory

CVSS V3.1

Score:
6.5
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.